Best Stocks to Buy: Adobe or Salesforce?

Stock Advisor reports a 930% total average return vs 185% for the S&P 500 (as of April 7, 2026); Adobe was not included in its latest top-10 picks. Motley Fool discloses it recommends and holds positions in Adobe and Salesforce and has an options spread on Adobe (long Jan 2028 $330 calls, short Jan 2028 $340 calls). The piece promotes AI upside and a paid report on a company supplying critical tech to Nvidia and Intel; video published April 5, 2026, with stock prices cited from April 3, 2026.

Analysis

AI feature rollouts are a durable but uneven tailwind for both Adobe and Salesforce: Adobe's moat is content + creator workflows, which creates optionality to bundle premium AI features and impose higher ARPU on professional users; Salesforce's moat is enterprise data and workflow lock-in, which enables per-account AI upsells that compound ARR more predictably. Second-order beneficiaries are GPU/cloud suppliers and MLOps vendors (NVDA, AMZN, MSFT, Databricks/DBX proxies), while smaller ISVs and ad-dependent studios face margin pressure as compute costs and feature parity compress business models.

Key catalysts live on 1–12 month horizons: upcoming earnings, Dreamforce/Adobe MAX equivalents, and first-quarter enterprise renewal season. Near-term (days–weeks) the market will trade sentiment around guidance/AI demos; medium-term (3–12 months) the story depends on measured monetization (ARPU uplift per seat) and compute-cost pass-through. Tail risks include rapid commoditization via open-source models, regulatory constraints on model training data or IP, and a sharp macro IT spend pullback—any of which could shave 20–40% off forward revenue growth assumptions within 12 months.

Volatility patterns favor directional, convex exposure rather than outright long stock: implied volatility for both names tends to reprice around earnings and product launches, creating windows to buy longer-dated asymmetric option structures and to sell short-dated premium. The market is implicitly pricing differentiated AI execution; the real test will be measurable revenue per account uplift over two consecutive quarters — absent that, multiples are exposed to >30% downside.

Contrarian read: consensus assumes AI is an immediate margin elevator; instead expect a multi-quarter investment phase where gross margins first compress (higher cloud/GPU spend) before ARPU recovers. That makes long-dated, asymmetric convexity (long calls or call spreads financed by short near-term premium) the cleaner way to express upside while capping time-decay risk.

Key Decisions for Investors

• Pair trade (6–12 months): Go long CRM via a 12-month 10–20% OTM call spread (size = base exposure) and short ADBE via selling 1–3 months of OTM covered calls or 1–3 month OTM call credit to fund the spread. R/R: target 20–35% relative outperformance for CRM vs ADBE; stop-loss if CRM/ADBE relative return < -12% within 3 months.
• Asymmetric upside (12–18 months): Buy long-dated (12–18 month) ADBE call calendar or 10–25% OTM call spread to capture multi-quarter monetization of GenAI features, funded by selling 30–60 day OTM calls into elevated IV. R/R: limited downside to premium paid, 3:1+ upside if ARPU acceleration shows in two consecutive quarters.
• Convexity on execution (3–6 months): Buy NVDA 6–12 month calls (or an equivalent GPU/cloud ETF exposure) sized as a tail hedge to both names; rationale is that outsized AI execution uplifts NVDA and cloud vendors. R/R: pays off asymmetrically if AI wins accelerate; cost = option premium as insurance.
• Volatility harvest (near-term, earnings windows): Sell small-size 10–25% OTM strangles on ADBE into pre-earnings IV if you believe demos/guidance risk is limited, but cap notional and buy wings (iron condor) to limit tail risk. R/R: collect premium with capped loss; exit 3–5 days before earnings or reduce if IV collapses.